In this study, we assess how effective pandemic and trivalent 2009-2010 seasonal vaccines were in preventing influenza-like illness (ILI) during the 2009 A(H1N1) pandemic in France. We also compare vaccine effectiveness against ILI versus laboratory-confirmed pandemic A(H1N1) influenza, and assess the possible bias caused by using non-specific endpoints and observational data.We estimated vaccine effectiveness by using the following formula: VE = (PPV-PCV)/(PPV(1-PCV)) × 100%, where PPV is the proportion vaccinated in the population and PCV the proportion of vaccinated influenza cases. People were considered vaccinated three weeks after receiving a dose of vaccine. ILI and pandemic A(H1N1) laboratory-confirmed cases were obtained from two...
While influenza vaccines aim to decrease the incidence of severe influenza among high-risk groups, e...
BACKGROUND: Influenza vaccination strategies aim at protecting high-risk population from severe outc...
While influenza vaccines aim to decrease the incidence of severe influenza among high-risk groups, e...
In this study, we assess how effective pandemic and trivalent 2009-2010 seasonal vaccines were in pr...
BACKGROUND: In this study, we assess how effective pandemic and trivalent 2009-2010 seasonal vaccine...
A multicentre case-control study based on sentinel practitioner surveillance networks from seven Eur...
A multicentre case-control study based on sentinel practitioner surveillance networks from seven Eur...
Following the global spread of pandemic influenza A(H1N1)2009, several pandemic vaccines have been r...
BACKGROUND: The effectiveness of currently licensed vaccines against influenza has not been clearly ...
Following the global spread of pandemic influenza A(H1N1)2009, several pandemic vaccines have been r...
Following the global spread of pandemic influenza A(H1N1)2009, several pandemic vaccines have been r...
<div><p>Background</p><p>The effectiveness of currently licensed vaccines against influenza has not ...
Influenza vaccination strategies aim at protecting high-risk population from severe outcomes. Estima...
Background: The effectiveness of currently licensed vaccines against influenza has not been clearly ...
While influenza vaccines aim to decrease the incidence of severe influenza among high-risk groups, e...
While influenza vaccines aim to decrease the incidence of severe influenza among high-risk groups, e...
BACKGROUND: Influenza vaccination strategies aim at protecting high-risk population from severe outc...
While influenza vaccines aim to decrease the incidence of severe influenza among high-risk groups, e...
In this study, we assess how effective pandemic and trivalent 2009-2010 seasonal vaccines were in pr...
BACKGROUND: In this study, we assess how effective pandemic and trivalent 2009-2010 seasonal vaccine...
A multicentre case-control study based on sentinel practitioner surveillance networks from seven Eur...
A multicentre case-control study based on sentinel practitioner surveillance networks from seven Eur...
Following the global spread of pandemic influenza A(H1N1)2009, several pandemic vaccines have been r...
BACKGROUND: The effectiveness of currently licensed vaccines against influenza has not been clearly ...
Following the global spread of pandemic influenza A(H1N1)2009, several pandemic vaccines have been r...
Following the global spread of pandemic influenza A(H1N1)2009, several pandemic vaccines have been r...
<div><p>Background</p><p>The effectiveness of currently licensed vaccines against influenza has not ...
Influenza vaccination strategies aim at protecting high-risk population from severe outcomes. Estima...
Background: The effectiveness of currently licensed vaccines against influenza has not been clearly ...
While influenza vaccines aim to decrease the incidence of severe influenza among high-risk groups, e...
While influenza vaccines aim to decrease the incidence of severe influenza among high-risk groups, e...
BACKGROUND: Influenza vaccination strategies aim at protecting high-risk population from severe outc...
While influenza vaccines aim to decrease the incidence of severe influenza among high-risk groups, e...